About MP Biomedicals
MP Biomedicals is a Healthcare company based in Santa Ana (United States) founded in 1959 by Milan Panic, and was acquired by Valiant in October 2015. Reagents for diagnostics, chemical and life science research. MP Biomedicals has completed 1 acquisition, including Qbiogene. Its chief executive, as recorded, is Kimberly Keniston. Its website mpbio.com draws about 112 thousand monthly visits. Its Indian entity Mp Biomedicals India Private Limited reported revenue of βΉ46.69 Cr. Its focus areas include Diversified Diagnostics.
Company details
MP Biomedicals was established in 1959 in Santa Ana, United States, by Milan Panic, a Serbian businessman and former Prime Minister of Yugoslavia. Reagents for diagnostics, chemical analysis, and life science research are provided through a product line exceeding 55,000 items, including assays, chemicals, labware, and instruments. Operations are centered on supporting laboratory and research applications in the biotechnology sector.
- Headquarters Santa Ana, United States
- Founders Milan Panic
- Stage Acquired
- SectorsHealthcare
- Website mpbio.com
- Social LinkedIn Facebook
- Acquired by Valiant (Oct 2015)
- Legal Name Mp Biomedicals India Private Limited
- Date of Incorporation 01 Apr, 2009
- Jurisdiction Navi Mumbai, Maharashtra, India
- Indian entity revenue₹46.69 Cr
FY 2024 · +37% YoY
- Indian entity net loss-₹24 Lakh
FY 2024 · -1% margin
- Indian entity EBITDA₹62.5 Lakh
FY 2024 · 1% margin
- Investors
- Investments & Acquisitions
- Acquired byValiant
(Oct 2015)
Associated legal entities of MP Biomedicals
MP Biomedicals operates through Mp Biomedicals India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mp Biomedicals India Private Limited CIN U24100MH2009PTC191394 | Active | 01 Apr 2009 | Navi Mumbai, Maharashtra | ₹46.7 Cr | 2 | View details |
Investors in MP Biomedicals
MP Biomedicals has secured backing from 1 investor. Prominent investors backing the company include Valiant CN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical intermediates and optical chemical products are manufactured. | 1995 | valiant-cn.com | Yantai, China |
Investor details for MP Biomedicals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Mp Biomedicals India Private Limited (MP Biomedicals)
Mp Biomedicals India Private Limited is the primary company behind MP Biomedicals. The board of Mp Biomedicals India Private Limited currently have 2 directors; the longest-serving is Du Yang, appointed in 2019. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Du Yang DIN 08534767 | Director | 12 Aug 2019 | 7 yrs 3 mo | Mp Biomedicals India Private Limited |
| Rahul Tewari DIN 08238673 | Director | 19 Jul 2024 | 2 yrs 3 mo | Mp Biomedicals India Private Limited |
People of MP Biomedicals
2 people are tracked at MP Biomedicals (2 in leadership).
| Name | Role | Group |
|---|---|---|
Milan Panic | Founder | Leadership |
Kimberly Keniston | CEO | Leadership |
Complete people profiles for MP Biomedicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MP Biomedicals
Figures of Mp Biomedicals India Private Limited, the primary company behind MP Biomedicals, for FY 2024. Revenue was ₹46.69 Cr (+37% year on year). Net loss was -₹24 Lakh (-1% margin). EBITDA was ₹62.5 Lakh (1% margin). Revenue has grown at a compounded annual rate of +12% over three years and +20% over five years.
- ₹46.69 CrRevenue · FY 2024 · +37% YoY
- -₹24 LakhNet loss · -1% margin
- ₹62.5 LakhEBITDA · 1% margin
- ₹12 LakhPaid-up capital
- +12%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mp Biomedicals India Private Limited are on its company page.
Detailed financial statements for MP Biomedicals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MP Biomedicals
MP Biomedicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Qbiogene.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Molecular biology products are supplied by Qbiogene. | qbiogene.com | 0 | Jul 2004 | β’β’β’β’ |
Complete acquisition details for MP Biomedicals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Web traffic of MP Biomedicals
The website of MP Biomedicals (mpbio.com) receives about 112.2K visits a month.
- Monthly visits112.2K
▲ 17% vs previous month
Websites whose visitors overlap most with MP Biomedicals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| caymanchem.com | 100% | 393.1K | #148,469 | View details | |
| invitrogen.com | 88% | 5.2K | #3,688,642 | View details | |
rpicorp.com | rpicorp.com | 87% | #1,292,794 | β | |
| peprotech.com | 84% | View details | |||
| bioline.com | 84% | 42.9K | #824,098 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for MP Biomedicals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
3 companies that operate in the same segment as MP Biomedicals (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | 336 | ||
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | |||
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | USD 4.45 M | 54 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mp Biomedicals
Complete news archive for MP Biomedicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MP Biomedicals
MP Biomedicals was founded in 1959.
MP Biomedicals is headquartered in Santa Ana, United States. It is registered at Santa Ana, California, United States.
Kimberly Keniston is the CEO of MP Biomedicals, as recorded in our data.
The primary company behind MP Biomedicals, Mp Biomedicals India Private Limited, reported revenue of βΉ46.69 Cr for FY 2024, up 37% year on year.
MP Biomedicals was established in 1959 in Santa Ana, United States, by Milan Panic, a Serbian businessman and former Prime Minister of Yugoslavia. Reagents for diagnostics, chemical analysis, and life science research are provided through a product line exceeding 55,000 items, including assays, chemicals, labware, and instruments. Operations are centered on supporting laboratory and research applications in the biotechnology sector.
MP Biomedicals has made 1 acquisition, including Qbiogene.
MP Biomedicals has 1 investor. Key investors include Valiant CN.
MP Biomedicals operates through Mp Biomedicals India Private Limited.
Yes. MP Biomedicals was acquired by Valiant in October 2015.
The legal entities of MP Biomedicals currently have 2 directors, including Du Yang, Rahul Tewari.
The website of MP Biomedicals receives about 112 thousand visits a month.

